GLPwatch
Trials (2036)
Page 7 of 34.
- Non-Alcoholic Fatty Liver Disease, the HEpatic Response to Oral Glucose, and the Effect of Semaglutide (NAFLD HEROES)
- A Study of the Efficacy and Safety of Semaglutide Injection in the Treatment of Type 2 Diabetes Mellitus
- The Effects of Exenatide on Oral Contraceptive Pharmacokinetics in Healthy Females
- Semaglutide for Treatment of People With Methamphetamine Use Disorder: the SHIFT Study
- Study of the Safety and Efficacy of MK-8521 Compared to Placebo and a Diabetes Drug in Participants With Type 2 Diabetes Mellitus (MK-8521-003)
- Liraglutide and a Calorie Restricted Diet Augments Weight Loss and Decreases Risk of Type 2 Diabetes and CVD.
- Effects of NNC0194-0499, Cagrilintide, and Semaglutide Alone or in Combinations on Liver Damage and Alcohol Use in People With Alcohol-related Liver Disease
- Physical and Chemical Study of Atherosclerosis Mechanisms
- A Master Protocol of Multiple Agents in Adults With Metabolic Dysfunction-Associated Steatotic Liver Disease (SYNERGY-Outcomes)
- Interest of GLP1 Analogues in Overweight Type 2 Diabetic Patients With Chronic Inflammatory Bowel Disease
- A Study of HS-20094 in T2DM Participants
- Retrospective Analysis for Patients With Metabolic Syndrome
- Primary Prevention and Uterine Preservation in Premenopausal Women With Obesity and Endometrial Hyperplasia
- GLP-1 Receptor Expression in CHI
- Influence of Appetite Related Hormones in Binge Eating Behaviour Among the Overweight and Obese
- A Clinical Trial Looking at the Comparability of 2 Different Forms of Semaglutide
- Prediction of the SURPASS-CVOT Cardiovascular Outcome Trial in Healthcare Claims Data
- Impact of Neuropathy on the Risk of Semaglutide-Induced Gastric Retention
- Vitamin C and Liraglutide Effects on Hypoglycemia-induced Oxidative Stress, Inflammation and Endothelial Dysfunction in Type 1 Diabetes.
- Coronary Flow Reserve Changes After Semaglutide Treatment
- Adiponectin in Patients With Metabolic Disorders
- Efficacy and Safety of Liraglutide in the Treatment of Obesity Combined With Metabolism Associated Fatty Liver Disease
- Out-Patient Study in Patients With Type 2 Diabetes Mellitus Who Are Taking no Diabetes Medication or Metformin Only
- A Post Marketing Surveillance (PMS) Study of Liraglutide in Subjects With Type 2 Diabetes Mellitus in India
- Efficacy and Safety of Liraglutide in Type 2 Diabetes With Lower Extremity Arterial Disease
- Evaluating the Safety and Effectiveness of Liraglutide in Subjects With Type 2 Diabetes
- A Research Study to See How Well CagriSema Helps People in East Asia With Excess Body Weight Lose Weight
- A Study of IBI362 in Participants With Type 2 Diabetes
- Ultrasound of the Knee in Obese Patients With Knee Osteoarthritis; Weight Loss
- Phase 2 Study of HEC88473 Injection in Subjects With Type 2 Diabetes Mellitus
- Open Randomized Study of Comparative Pharmacokinetics and Biosimilarity of GP40221 (GEROPHARM LLC, Russia) and Ozempic®.
- Multiple-dose Tolerability and Pharmacokinetic of IBI362 in Chinese Patients With T2DM
- A Study of Orforglipron (LY3502970) in Adult Participants With Obesity or Overweight With Weight-Related Comorbidities
- A Randomised, Double-blind, Placebo-controlled Trial to Assess Safety, Tolerability and Pharmacokinetics of Liraglutide in Obese Adolescent Subjects Aged 12 to 17 Years
- Comparison of Body Composition Changes With Weight Loss Interventions
- The Efficacy of Insulin Degludec/Liraglutide as add-on Therapy in Controlling Glycaemia in Adults With Type 2 Diabetes Inadequately Controlled on Sulphonylurea With or Without Metformin Therapy
- Research Study to Look at How Well Semaglutide Works in People Living With Heart Failure, Obesity and Type 2 Diabetes
- Study of the Safety and Tolerability of Switching to ITCA 650 in Patients With Type 2 Diabetes Receiving Liraglutide
- Semaglutide Effects on Sleep Apnea in Patients With Type 2 Diabetes/Obesity and Comorbid Obstructive Sleep Apnea
- A Research Study to Investigate the Effects of CagriSema Compared to Placebo in People With Type 2 Diabetes and Painful Diabetic Peripheral Neuropathy
- Comparison of the Efficacy and Safety of Insulin Glargine/Lixisenatide Fixed Ratio Combination to Insulin Glargine in Patients With Type 2 Diabetes Insufficiently Controlled on Basal Insulin
- Ixekizumab Concomitantly Administered With Tirzepatide in Adults With Psoriatic Arthritis and Obesity or Overweight
- The Efficacy and Safety of Liraglutide on Body Weight Loss in Obese and Overweight Patients
- Effectiveness of Microdosed GLP-1 in Improving Health, Quality of Life, and Longevity Measures
- Investigating How CagriSema, Semaglutide and Cagrilintide Regulate Insulin Effects in the Body of People With Type 2 Diabetes
- Comparison of the Efficacy and Safety of Two Intensification Strategies in Subjects With Type 2 Diabetes Inadequately Controlled on Basal Insulin and Metformin
- EQW, DAPA, EQW/DAPA, DAPA/MET ER and PHEN/TPM ER in Obese Women With PolycysticOvary Syndrome (PCOS)
- A Research Study to Find Out How Semaglutide Works in the Kidneys Compared to Placebo, in People With Type 2 Diabetes and Chronic Kidney Disease (the REMODEL Trial)
- GLP-1 Receptors in Normal Skin and Skin From Patients With Psoriasis
- Continuous Glucose Monitoring Evaluation of Exenatide Twice Daily Versus Insulin Glargine
- New Imaging Procedure for the Localisation of Insulinoma
- Polycystic Ovary Syndrome and Liraglutide
- Harmonizing RCT-Duplicate Emulations In A Real World Replication Program (HARRP)
- Safety and Tolerability of NN9068 in Healthy Male Volunteers
- Comparison Between GLP 1 Analogues and DPP 4 Inhibitors in Type 1 Diabetes Mellitus
- The Vascular Effects of Exenatide Versus Metformin in Patients With Pre-Diabetes
- Investigating the Influence of Omeprazole on the Pharmacokinetics of Oral Semaglutide in Healthy Subjects
- Efficacy and Safety of Semaglutide Once Weekly Versus Insulin Glargine Once Daily as add-on to Metformin With or Without Sulphonylurea in Insulin-naïve Subjects With Type 2 Diabetes
- DECREASE: Dapagliflozin Plus Exenatide on Central REgulation of Appetite in diabeteS typE 2
- A Research Study to Understand How People With Type 2 Diabetes Take Ozempic® and if the Ozempic®App Helps Them Stay on This Treatment